ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2903

Transition of Nailfold Microangiopathy throughout Different Patterns of Microvascular Damage and Correlations with Organ Involvement in Systemic Sclerosis: A Twelve Year Follow-up

Alberto Sulli1, Sabrina Paolino1, Barbara Ruaro1, Amelia Chiara Trombetta1, Vanessa Smith2, Maurizio Cutolo1 and Carmen Pizzorni1, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy, 2Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Nailfold capillaroscopy is the validated technique to assess scleroderma microangiopathy, an early and dynamic event that may progress through different patterns of microvascular damage (“early”, “active” and “late”) during follow-up (1,2). The time of transition is variable among patients, and it was little investigated (2). Several studies demonstrated correlations between microvascular damage extent and organ involvement degree (2-4). The aim of this longitudinal study was to investigate the time of transition of nailfold microangiopathy throughout different patterns of microvascular damage in SSc, assessing correlations with organ involvement.

Methods: Thirty-four SSc patients according to LeRoy criteria (mean age 57±11 years) with the “early” pattern of nailfold microangiopathy at first capillaroscopic visit were enrolled and followed for a mean time of 12±3 years. Only SSc patients with fully complete documentation were included into the study. The pattern of microangiopathy was recorded and the microangiopathy evolution score (MES) calculated by nailfold videocapillaroscopy (NVC) at each visit, as previously reported (1,2); organ involvement and antinuclear antibody (ANA) profile were also assessed.

Results: After a mean twelve years follow-up, 12 (35%) patients were still showing the “early” scleroderma-pattern, while the NVC pattern of microangiopathy was changed in 65% of the patients. The NVC pattern was found “active” in 10 patients (30%) and “late” in 12 patients (35%). The median time of progression from the “early” to the “active” pattern was 31 months, from “active” to “late” 38 months, and from “early” to “late” 66 months. In the subgroup of patients whose microangiopathy progressed from the “early” to the “late” NVC pattern through the “active” pattern, the median time of progression from the “early” to the “active” pattern was only 14 months, while in the subgroup of patients whose microangiopathy progressed only from the “early” to the “active” NVC pattern it was 42 months. A correlation was confirmed between microvascular damage extent and organ involvement degree, as MES progressively increased and organ involvement was progressively greater in SSc patients with “early”, “active” and “late” NVC pattern of microangiopathy, respectively. The median time of progression from “early” to “late” pattern was shorter in SSc patients with either nucleolar IIF ANA pattern or Scl70 autoantibodies.

Conclusion: This study confirms the progression of nailfold microangiopathy through different patterns of microvascular damage in almost 65% of SSc patients. Patients showing a fast progression from the “early” to the “active” NVC pattern of microangiopathy (one year), as well as positive ANA with either a nucleolar IIF pattern or Scl70 positivity should be strictly monitored since at risk of rapid progression to the “late” NVC pattern of microangiopathy which is linked to a larger risk of organ involvement. References.
1. Cutolo M, et al. Rheumatology 2004;43:719-26. 2. Sulli A, et al. Arthritis Rheum. 2012;64:821-5. 3. Ingegnoli F, et al. Microvasc Res 2013;89:122-8. 4. Smith V, et al. J Rheumatol. 2013;40:2023-8.


Disclosure: A. Sulli, None; S. Paolino, None; B. Ruaro, None; A. C. Trombetta, None; V. Smith, None; M. Cutolo, Actelion, BMS, Sanofi-Aventis, 2,Actelion, BMS, Sanofi-Aventis, 5; C. Pizzorni, None.

To cite this abstract in AMA style:

Sulli A, Paolino S, Ruaro B, Trombetta AC, Smith V, Cutolo M, Pizzorni C. Transition of Nailfold Microangiopathy throughout Different Patterns of Microvascular Damage and Correlations with Organ Involvement in Systemic Sclerosis: A Twelve Year Follow-up [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/transition-of-nailfold-microangiopathy-throughout-different-patterns-of-microvascular-damage-and-correlations-with-organ-involvement-in-systemic-sclerosis-a-twelve-year-follow-up/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transition-of-nailfold-microangiopathy-throughout-different-patterns-of-microvascular-damage-and-correlations-with-organ-involvement-in-systemic-sclerosis-a-twelve-year-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology